On one side, MEG3 was overexpressed in acute promyelocytic leukemia (APL), while exerting antitumor function in AML cell lines (Liu et al., 2019; Zimta et al., 2019). The gene discussed is MEG3; the disease is acute promyelocytic leukemia.